<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.neurologylive.com/view/atogepant-gains-european-approval-acute-preventive-migraine-therapy</loc><lastmod>2026-06-03T21:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Atogepant Gains European Approval as Acute and Preventive Migraine Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/improving-access-cognitive-screening-ms-care-elizabeth-gromisch</loc><lastmod>2026-06-03T19:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Improving Access to Cognitive Screening in Multiple Sclerosis Care: Elizabeth S. Gromisch, PhD, MSCS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/what-clinicians-need-to-know-about-emerging-stem-cell-therapies</loc><lastmod>2026-06-03T15:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T15:00:00Z</news:publication_date>
        <news:title><![CDATA[What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurovoices-rachel-kenney-integrating-oct-2024-mcdonald-criteria-ms</loc><lastmod>2026-06-03T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T10:00:00Z</news:publication_date>
        <news:title><![CDATA[NeuroVoices: Rachel Kenney, PhD, on Integrating OCT Into the 2024 McDonald Criteria for Multiple Sclerosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/sky-0515-demonstrates-sustained-mutant-huntingtin-lowering-latest-phase-1-2-study-update</loc><lastmod>2026-06-02T22:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T22:00:00Z</news:publication_date>
        <news:title><![CDATA[SKY-0515 Demonstrates Sustained Mutant Huntingtin Lowering in Latest Phase 1/2 Study Update]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/factors-associated-response-cognitive-rehabilitation-progressive-ms-cecilia-meza</loc><lastmod>2026-06-02T19:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Factors Associated With Response to Cognitive Rehabilitation in Progressive MS: Cecilia Meza, MA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/understanding-ocrelizumab-safe-efficacious-profile-preconceiving-women-ms-kristen-krysko</loc><lastmod>2026-06-02T17:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Understanding Ocrelizumab’s Safe and Efficacious Profile in Preconceiving Women With MS: Kristen Krysko, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/advanced-therapy-with-apomorphine-pump-in-parkinson-s-disease</loc><lastmod>2026-06-02T12:05:00Z</lastmod><news:news><news:publication_date>2026-06-02T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Advanced Therapy with Apomorphine Pump in Parkinson’s Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/managing-off-time-in-parkinson-s-disease</loc><lastmod>2026-06-02T12:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Managing OFF Time in Parkinson’s Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/inside-development-isscr-new-parkinson-disease-stem-cell-program</loc><lastmod>2026-06-02T12:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Inside the Development of ISSCR’s New Parkinson Disease Stem Cell Program]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/refining-myelitis-criteria-reduce-misdiagnosis-improve-care-clinical-practice</loc><lastmod>2026-06-02T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Refining Myelitis Criteria to Reduce Misdiagnosis and Improve Care in Clinical Practice]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/new-clinical-data-reinforce-opakalim-potential-selective-antiseizure-therapy-option</loc><lastmod>2026-06-01T19:10:39.426Z</lastmod><news:news><news:publication_date>2026-06-01T19:10:39.426Z</news:publication_date>
        <news:title><![CDATA[New Clinical Data Reinforce Opakalim’s Potential as a Selective Antiseizure Therapy Option]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/real-world-registry-data-support-eculizumab-ravulizumab-effective-treatments-nmosd</loc><lastmod>2026-06-01T15:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Real-World Registry Data Support Eculizumab, Ravulizumab as Effective Treatments for NMOSD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/this-week-on-neurologylive-june-1-2026</loc><lastmod>2026-06-01T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T10:00:00Z</news:publication_date>
        <news:title><![CDATA[This Week on NeurologyLive® — June 1, 2026]]></news:title>
        <news:keywords><![CDATA[NeurologyLive this week,neurology news this week,neurology news,neurology news highlights,this week in neurology news,this week in neurology,news in neurology]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurologylive-brain-games-may-31-2026</loc><lastmod>2026-05-22T10:00:00.000Z</lastmod><news:news><news:publication_date>2026-05-31T10:00:00Z</news:publication_date>
        <news:title><![CDATA[NeurologyLive® Brain Games: May 31, 2026]]></news:title>
        <news:keywords><![CDATA[Brain Games,Quiz,NeurologyLive Brain Games,NeurologyLive quiz,Neurology quiz,Neuro quiz,neurology quiz questions,clinical quiz,Medical quiz]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/patient-perspective-long-term-ms-management-treatment-decision-making-jamie-lynn-sigler</loc><lastmod>2026-05-30T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-30T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Patient Perspective on Long-Term MS Management and Treatment Decision-Making: Jamie Lynn Sigler]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/evolution-stroke-rehabilitation-advances-recovery-neuromodulation</loc><lastmod>2026-05-30T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-30T15:00:00Z</news:publication_date>
        <news:title><![CDATA[The Evolution of Stroke Rehabilitation: Advances in Recovery and Neuromodulation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/glp-1s-improve-ms-physical-activity-bla-submitted-z-rostudirsen-ofatumumab-outperforms-rituximab-nmosd-study</loc><lastmod>2026-01-31T12:00:00.000Z</lastmod><news:news><news:publication_date>2026-05-30T11:00:00Z</news:publication_date>
        <news:title><![CDATA[GLP-1s Improve MS Physical Activity, BLA Submitted for Z-Rostudirsen, Ofatumumab Outperforms Rituximab in NMOSD Study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/high-efficacy-therapy-strategies-aggressive-ms-patricia-coyle</loc><lastmod>2026-05-29T22:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T22:00:00Z</news:publication_date>
        <news:title><![CDATA[High-Efficacy Therapy Strategies for Aggressive MS: Patricia Coyle, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/cmsc-2026-real-world-analysis-supports-ocrelizumab-use-pediatric-onset-ms</loc><lastmod>2026-05-29T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T15:00:00Z</news:publication_date>
        <news:title><![CDATA[CMSC 2026: Real-World Analysis Supports Ocrelizumab Use in Pediatric-Onset Multiple Sclerosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/setting-treatment-goals-and-managing-expectations-in-cidp</loc><lastmod>2026-05-29T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-29T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Setting Treatment Goals and Managing Expectations in CIDP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/phase-3-fenfluramine-trial-design-in-cdd-study-population-endpoints-and-dosing-strategy</loc><lastmod>2026-05-29T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Phase 3 Fenfluramine Trial Design in CDD: Study Population, Endpoints, and Dosing Strategy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/monitoring-cidp-treatment-response-with-objective-outcome-measures</loc><lastmod>2026-05-29T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Monitoring CIDP Treatment Response with Objective Outcome Measures]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/positioning-inebilizumab-a-distinct-approach-in-the-evolving-gmg-treatment-landscape</loc><lastmod>2026-05-29T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Positioning Inebilizumab: A Distinct Approach in the Evolving gMG Treatment Landscape]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/episode-167-new-aasm-guidance-combination-treatment-for-chronic-insomnia</loc><lastmod>2026-05-29T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Episode 167: New AASM Guidance on Combination Treatment for Chronic Insomnia]]></news:title>
        <news:keywords><![CDATA[Mind Moments,Podcasts,Mind Moments podcast,NeurologyLive podcast,Stroke,exosome,Aruna Bio,Stephen from,Neuroprotection,Cerebroprotection,neuroprotection,anti-inflammatory,inflammation]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/beyond-bedside-broader-scope-nursing-neurology</loc><lastmod>2026-05-28T22:00:51.159Z</lastmod><news:news><news:publication_date>2026-05-28T22:00:51.159Z</news:publication_date>
        <news:title><![CDATA[Beyond the Bedside: The Broader Scope of Nursing in Neurology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/real-world-ozanimod-data-relapsing-remitting-ms-low-relapse-rates-stable-disability-over-years</loc><lastmod>2026-05-28T19:00:48.500Z</lastmod><news:news><news:publication_date>2026-05-28T19:00:48.500Z</news:publication_date>
        <news:title><![CDATA[Real-World Ozanimod Data in Relapsing-Remitting MS Show Low Relapse Rates and Stable Disability Over 3 Years]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/review-suggests-ferritin-influence-ms-progression-repair</loc><lastmod>2026-05-28T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Review Suggests Ferritin May Influence MS Progression and Repair ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/glp-1-receptor-agonists-linked-to-improved-physical-activity-multiple-sclerosis</loc><lastmod>2026-05-28T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T15:00:00Z</news:publication_date>
        <news:title><![CDATA[GLP-1 Receptor Agonists Linked to Improved Physical Activity in Multiple Sclerosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/practical-use-of-vorasidenib-patient-selection-monitoring-and-real-world-considerations</loc><lastmod>2026-05-28T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Practical Use of Vorasidenib: Patient Selection, Monitoring, and Real-World Considerations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/three-year-extension-findings-reinforce-frexalimab-safety-and-efficacy-relapsing-ms</loc><lastmod>2026-05-28T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Three-Year Extension Findings Reinforce Frexalimab’s Safety and Efficacy in Relapsing MS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/complement-inhibition-may-stabilize-aqp4-positive-nmosd-after-inebilizumab-failure-analysis-suggests</loc><lastmod>2026-05-27T22:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Complement Inhibition May Stabilize AQP4-Positive NMOSD After Inebilizumab Failure, Analysis Suggests]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/phase-4-study-reports-improved-patient-reported-outcomes-ublituximab-ms</loc><lastmod>2026-05-27T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Phase 4 Study Reports Improved Patient-Reported Outcomes With Ublituximab in Multiple Sclerosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/ozanimod-preserves-multiple-sclerosis-cognition-new-3-year-analysis</loc><lastmod>2026-05-27T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Ozanimod Preserves Multiple Sclerosis Cognition in New 3-Year Analysis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/tourette-syndrome-awareness-month-perspectives-from-joohi-jimenez-shahed</loc><lastmod>2026-05-27T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Tourette Syndrome Awareness Month: Perspectives From Joohi Jimenez-Shahed, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/dyne-submits-bla-z-rostudirsen-exon-51-skipping-duchenne-muscular-dystrophy</loc><lastmod>2026-05-26T19:28:48.366Z</lastmod><news:news><news:publication_date>2026-05-26T19:28:48.366Z</news:publication_date>
        <news:title><![CDATA[Dyne Submits BLA for Z-Rostudirsen in Exon 51 Skipping Duchenne Muscular Dystrophy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/understanding-off-time-in-parkinson-s-disease</loc><lastmod>2026-05-26T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-26T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Understanding OFF Time in Parkinson’s Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/recognizing-off-time-in-parkinson-s-disease</loc><lastmod>2026-05-26T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Recognizing OFF Time in Parkinson’s Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/nursing-role-neurology-care</loc><lastmod>2026-05-26T10:00:46.611Z</lastmod><news:news><news:publication_date>2026-05-26T10:00:46.611Z</news:publication_date>
        <news:title><![CDATA[Nursing's Role in Neurology Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/assessing-efgartigimod-acute-nmosd-phase-2-fact-trial</loc><lastmod>2026-05-26T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Assessing Efgartigimod for Acute Neuromyelitis Optica Spectrum Disorder: The Phase 2 FACT Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/oligomerix-completes-phase-1a-study-olx-07010-alzheimer-disease</loc><lastmod>2026-05-25T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-25T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Oligomerix Completes Phase 1a Study of OLX-07010 for Alzheimer Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/this-week-on-neurologylive-may-25-2026</loc><lastmod>2026-05-25T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-25T10:00:00Z</news:publication_date>
        <news:title><![CDATA[This Week on NeurologyLive® — May 25, 2026]]></news:title>
        <news:keywords><![CDATA[NeurologyLive this week,neurology news this week,neurology news,neurology news highlights,this week in neurology news,this week in neurology,news in neurology]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/amlenetug-shows-slowing-msa-progression-despite-missing-phase-2-trial-primary-end-point</loc><lastmod>2026-05-24T16:00:00Z</lastmod><news:news><news:publication_date>2026-05-24T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Amlenetug Shows Slowing of Multiple System Atrophy Progression Despite Missing Phase 2 Trial Primary End Point]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurologylive-brain-games-may-24-2026</loc><lastmod>2026-05-22T10:00:00.000Z</lastmod><news:news><news:publication_date>2026-05-24T10:00:00Z</news:publication_date>
        <news:title><![CDATA[NeurologyLive® Brain Games: May 24, 2026]]></news:title>
        <news:keywords><![CDATA[Brain Games,Quiz,NeurologyLive Brain Games,NeurologyLive quiz,Neurology quiz,Neuro quiz,neurology quiz questions,clinical quiz,Medical quiz]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/ofatumumab-outperforms-rituximab-reducing-relapse-risk-mogad-study-shows</loc><lastmod>2026-05-23T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-23T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Ofatumumab Outperforms Rituximab in Reducing Relapse Risk of MOGAD, Study Shows]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/biomarkers-complement-inhibition-and-the-future-of-cidp-care</loc><lastmod>2026-05-23T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-23T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Biomarkers, Complement Inhibition, and the Future of CIDP Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/fda-accepts-nda-asundexian-dysport-noninferior-botox-safety-profile-gmg-bridging-gaps-discussion</loc><lastmod>2026-05-23T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-23T10:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA Accepts NDA for Asundexian, Dysport Noninferior Botox in Safety Profile, gMG Bridging the Gaps Discussion]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurologylive-friday-5-may-22-2026</loc><lastmod>2026-05-22T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T19:00:00Z</news:publication_date>
        <news:title><![CDATA[NeurologyLive® Friday 5 — May 22, 2026]]></news:title>
        <news:keywords><![CDATA[NeurologyLive Friday 5,Friday 5,NeurologyLive top 5,Neurology top 5,Neurology news top 5,Neurology news,Neurology news updates,top Neurology news]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurologylive-friday-5-may-29-2026</loc><lastmod>2026-05-22T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T19:00:00Z</news:publication_date>
        <news:title><![CDATA[NeurologyLive® Friday 5 — May 29, 2026]]></news:title>
        <news:keywords><![CDATA[NeurologyLive Friday 5,Friday 5,NeurologyLive top 5,Neurology top 5,Neurology news top 5,Neurology news,Neurology news updates,top Neurology news]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/stroke-awareness-month-highlights-research-exploring-cardiovascular-rehabilitation-stroke-recovery-part-2</loc><lastmod>2026-05-22T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Stroke Awareness Month Highlights Research Exploring Cardiovascular Rehabilitation in Stroke Recovery: Part 2 ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/emerging-targeted-therapies-in-cidp</loc><lastmod>2026-05-22T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-22T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Emerging Targeted Therapies in CIDP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/brain-chat-tremors-explained-with-dr-branson-dr-keisha-young</loc><lastmod>2026-05-22T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Brain Chat: Tremors Explained With Dr. Tiffany Branson and Dr. Keisha Young]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/evaluating-subcutaneous-immunoglobulin-therapy-in-cidp</loc><lastmod>2026-05-22T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Evaluating Subcutaneous Immunoglobulin Therapy in CIDP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/tdis-analysis-defines-4-point-mcid-tardive-dyskinesia-patient-reported-burde</loc><lastmod>2026-05-22T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Study Suggests Clinically Meaningful Improvement Benchmark for TDIS in Tardive Dyskinesia]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/b-cell-depletion-in-focus-pharmacodynamic-and-biomarker-insights-from-mint</loc><lastmod>2026-05-22T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T12:00:00Z</news:publication_date>
        <news:title><![CDATA[B-Cell Depletion in Focus: Pharmacodynamic and Biomarker Insights From MINT]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/understanding-cdkl5-deficiency-disorder-clinical-burden-and-treatment-challenges</loc><lastmod>2026-05-22T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Understanding CDKL5 Deficiency Disorder: Clinical Burden and Treatment Challenges]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/novel-digital-measures-for-tracking-disease-progression-duchenne-muscular-dystrophy-beyond-loss-ambulation</loc><lastmod>2026-05-21T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Novel Digital Measures for Tracking Disease Progression in Duchenne Muscular Dystrophy Beyond Loss of Ambulation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/hybridopa-motor-nonmotor-gains-phase-2a-parkinson-disease-trial</loc><lastmod>2026-05-21T15:00:38.750Z</lastmod><news:news><news:publication_date>2026-05-21T15:00:38.750Z</news:publication_date>
        <news:title><![CDATA[Hybridopa Shows Motor, Nonmotor Gains in Phase 2a Parkinson Disease Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/dysport-demonstrates-comparable-safety-longer-duration-than-botox-phase-4-trial-upper-limb-spasticity</loc><lastmod>2026-05-21T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Dysport Demonstrates Comparable Safety, Longer Duration Than Botox in Phase 4 Trial of Upper Limb Spasticity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/earlier-intervention-in-idh-mutant-glioma-rethinking-treatment-after-resection</loc><lastmod>2026-05-21T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Earlier Intervention in IDH-Mutant Glioma: Rethinking Treatment After Resection]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/anup-patel-expanding-role-of-ai-and-collaboration-pediatric-epilepsy-research</loc><lastmod>2026-05-21T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Anup Patel, MD, on Expanding Role of AI and Collaboration in Pediatric Epilepsy Research]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/stroke-awareness-month-highlights-research-exploring-cardiovascular-rehabilitation-stroke-recovery</loc><lastmod>2026-05-20T22:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Stroke Awareness Month Highlights Research Exploring Cardiovascular Rehabilitation in Stroke Recovery: Part 1 ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/key-themes-2026-brain-spine-symposium-neurology-practice-warren-selman</loc><lastmod>2026-05-20T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Key Themes of the 2026 Brain & Spine Symposium for Neurology Practice: Warren Selman, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/fda-grants-priority-review-levacetylleucine-ataxia-telangiectasia-potentially-positioning-first-approved-therapy</loc><lastmod>2026-05-20T17:01:00Z</lastmod><news:news><news:publication_date>2026-05-20T17:01:00Z</news:publication_date>
        <news:title><![CDATA[FDA Grants Priority Review to Levacetylleucine for Ataxia-Telangiectasia, Potentially Positioning First Approved Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurology-nursing-beyond-bedside-hernandez-blain</loc><lastmod>2026-05-20T15:00:38.541Z</lastmod><news:news><news:publication_date>2026-05-20T15:00:38.541Z</news:publication_date>
        <news:title><![CDATA[Neurology Nursing Beyond the Bedside: Jeffrey Hernandez, DNP, APRN, and Bonnie Blain, RN]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/complexity-gmg-bridging-gaps-diagnosis-treatment-equity</loc><lastmod>2026-05-20T13:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Complexity in Myasthenia Gravis: Bridging the Gaps in Diagnosis, Treatment, and Equitable Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurovoices-jerome-siegel-locus-coeruleus-neuron-loss-key-pathologic-feature-narcolepsy</loc><lastmod>2026-05-20T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T10:00:00Z</news:publication_date>
        <news:title><![CDATA[NeuroVoices: Jerome Siegel, PhD, on Locus Coeruleus Neuron Loss as a Key Pathologic Feature of Narcolepsy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/early-treatment-decisions-in-parkinson-s-disease</loc><lastmod>2026-05-19T17:14:00.315Z</lastmod><news:news><news:publication_date>2026-05-19T17:14:00.315Z</news:publication_date>
        <news:title><![CDATA[Early Treatment Decisions in Parkinson’s Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/from-symptoms-to-diagnosis-in-parkinson-s-disease</loc><lastmod>2026-05-19T17:01:36.725Z</lastmod><news:news><news:publication_date>2026-05-19T17:01:36.725Z</news:publication_date>
        <news:title><![CDATA[From Symptoms to Diagnosis in Parkinson’s Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/dt216p2-dose-dependent-frataxin-increases-clinical-improvements-weeks-dosing-friedreich-ataxia</loc><lastmod>2026-05-19T17:00:15.827Z</lastmod><news:news><news:publication_date>2026-05-19T17:00:15.827Z</news:publication_date>
        <news:title><![CDATA[DT-216P2 Shows Dose-Dependent Frataxin Increases and Clinical Improvements After 4 Weeks of IV Dosing in Friedreich Ataxia]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/fda-grants-priority-review-bayer-asundexian-secondary-stroke-prevention</loc><lastmod>2026-05-19T16:20:24.916Z</lastmod><news:news><news:publication_date>2026-05-19T16:20:24.916Z</news:publication_date>
        <news:title><![CDATA[FDA Grants Priority Review to Bayer’s Asundexian for Secondary Stroke Prevention]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/methylprednisolone-taper-reduces-posttraumatic-headache-severity-after-mild-tbi</loc><lastmod>2026-05-19T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Methylprednisolone Taper Reduces Posttraumatic Headache Severity After Mild TBI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/stroke-awareness-month-highlights-emerging-therapies-opportunities-recovery-care</loc><lastmod>2026-05-19T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Stroke Awareness Month Highlights Emerging Therapies and Opportunities in Recovery Care ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/study-identifies-endotypic-traits-associated-eds-osa</loc><lastmod>2026-05-18T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Study Identifies Endotypic Traits Associated With Excessive Daytime Sleepiness in Obstructive Sleep Apnea]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/clinical-potential-the-zeto-one-point-of-care-eeg-system</loc><lastmod>2026-05-18T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Clinical Potential of the Zeto One Point-of-Care EEG System]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/phase-3-synairgy-data-mechanistic-review-strengthen-scientific-foundation-oral-osa-therapy-ad109</loc><lastmod>2026-05-18T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Phase 3 SynAIRgy Data, Mechanistic Review Strengthen Scientific Foundation for Apnimed’s Oral OSA Therapy AD109]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/this-week-on-neurologylive-may-18-2026</loc><lastmod>2026-05-18T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T10:00:00Z</news:publication_date>
        <news:title><![CDATA[This Week on NeurologyLive® — May 18, 2026]]></news:title>
        <news:keywords><![CDATA[NeurologyLive this week,neurology news this week,neurology news,neurology news highlights,this week in neurology news,this week in neurology,news in neurology]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/oct-emerging-diagnostic-tool-pediatric-onset-ms-scott-grossman</loc><lastmod>2026-05-17T16:00:00Z</lastmod><news:news><news:publication_date>2026-05-17T16:00:00Z</news:publication_date>
        <news:title><![CDATA[OCT as an Emerging Diagnostic Tool in Pediatric-Onset Multiple Sclerosis: Scott Grossman, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurologylive-brain-games-may-17-2026</loc><lastmod>2026-05-15T10:00:00.000Z</lastmod><news:news><news:publication_date>2026-05-17T10:00:00Z</news:publication_date>
        <news:title><![CDATA[NeurologyLive® Brain Games: May 17, 2026]]></news:title>
        <news:keywords><![CDATA[Brain Games,Quiz,NeurologyLive Brain Games,NeurologyLive quiz,Neurology quiz,Neuro quiz,neurology quiz questions,clinical quiz,Medical quiz]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/understanding-parkinson-disease-through-personalized-lens-perspectives-from-kelsey-jensen</loc><lastmod>2026-05-16T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-16T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Understanding Parkinson Disease Through a Personalized Lens: Perspectives From Kelsey Jensen, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/understanding-downstream-impacts-of-delayed-cidp-diagnosis-karen-lynch</loc><lastmod>2026-05-16T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-16T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Understanding the Downstream Impacts of Delayed CIDP Diagnosis: Karen Lynch, MD, MRCPI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/fda-makes-multiple-decisions-vemircopan-misses-primary-end-point-aan-2026-top-interviews</loc><lastmod>2026-05-16T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-16T10:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA Makes Multiple Decisions, Vemircopan Misses Primary End Point, AAN 2026: Top Interviews]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/role-nurses-neurology-care-hernandez-blain</loc><lastmod>2026-05-15T22:00:07.785Z</lastmod><news:news><news:publication_date>2026-05-15T22:00:07.785Z</news:publication_date>
        <news:title><![CDATA[The Role of Nurses in Neurology Care: Jeffrey Hernandez, DNP, APRN, and Bonnie Blain, RN]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurologylive-friday-5-may-15-2026</loc><lastmod>2026-05-15T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T19:00:00Z</news:publication_date>
        <news:title><![CDATA[NeurologyLive® Friday 5 — May 15, 2026]]></news:title>
        <news:keywords><![CDATA[NeurologyLive Friday 5,Friday 5,NeurologyLive top 5,Neurology top 5,Neurology news top 5,Neurology news,Neurology news updates,top Neurology news]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/overviewing-phase-3-nimble-study-cemdisiran-generalized-mg-tuan-vu</loc><lastmod>2026-05-15T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Overviewing Phase 3 NIMBLE Study of Cemdisiran in Generalized Myasthenia Gravis: Tuan Vu, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/machine-learning-driven-cognitive-screening-tool-aims-improve-early-dementia-detection-adrian-owen-obe-phd</loc><lastmod>2026-05-15T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Machine Learning–Driven Cognitive Screening Tool Aims to Improve Early Dementia Detection: Adrian Owen, OBE, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/optimizing-and-individualizing-ivig-therapy-in-cidp</loc><lastmod>2026-05-15T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-15T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Optimizing and Individualizing IVIG Therapy in CIDP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/understanding-the-3-year-findings-behind-amt-130-huntington-disease-victor-sung</loc><lastmod>2026-05-15T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Understanding the 3-Year Findings Behind AMT-130 in Huntington Disease: Victor Sung, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/real-world-evidence-for-immunoglobulin-therapy-in-cidp</loc><lastmod>2026-05-15T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Real-World Evidence for Immunoglobulin Therapy in CIDP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/sustained-benefit-over-time-interpreting-52-week-efficacy-from-mint</loc><lastmod>2026-05-15T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Sustained Benefit Over Time: Interpreting 52-Week Efficacy From MINT]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/episode-166-understanding-rnfl-asymmetry-as-biomarker-in-pediatric-ms</loc><lastmod>2026-05-15T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Episode 166: Understanding RNFL Asymmetry as a Biomarker in Pediatric MS]]></news:title>
        <news:keywords><![CDATA[Mind Moments,Podcasts,Mind Moments podcast,NeurologyLive podcast,Stroke,exosome,Aruna Bio,Stephen from,Neuroprotection,Cerebroprotection,neuroprotection,anti-inflammatory,inflammation]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/topline-phase-2-celia-results-show-diranersen-misses-primary-end-point-early-ad</loc><lastmod>2026-05-14T20:46:12.097Z</lastmod><news:news><news:publication_date>2026-05-14T20:46:12.097Z</news:publication_date>
        <news:title><![CDATA[Topline Phase 2 CELIA Results Show Diranersen Misses Primary End Point in Early Alzheimer Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/gene-therapy-rgx-202-meets-primary-end-point-pivotal-affinity-duchenne-study-supporting-accelerated-approval-plans</loc><lastmod>2026-05-14T20:00:42.550Z</lastmod><news:news><news:publication_date>2026-05-14T20:00:42.550Z</news:publication_date>
        <news:title><![CDATA[Gene Therapy RGX-202 Meets Primary End Point in Pivotal AFFINITY DUCHENNE Study, Supporting Accelerated Approval Plans]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/stroke-awareness-month-expanding-role-neuroimaging-stroke-intervention</loc><lastmod>2026-05-14T18:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Stroke Awareness Month: The Expanding Role of Neuroimaging in Stroke Intervention]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/2026-aan-annual-meeting-top-interviews-expert-perspectives</loc><lastmod>2026-05-14T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T15:00:00Z</news:publication_date>
        <news:title><![CDATA[2026 AAN Annual Meeting: Top Interviews and Expert Perspectives ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/exploring-seizure-reduction-in-indigo-signals-limitations-and-clinical-interpretation</loc><lastmod>2026-05-14T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Exploring Seizure Reduction in INDIGO: Signals, Limitations, and Clinical Interpretation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/highlighting-key-clinical-research-trends-from-2026-aan-annual-meeting</loc><lastmod>2026-05-14T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Highlighting Key Clinical and Research Trends From the 2026 AAN Annual Meeting]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurostimulation-shows-sustained-seizure-reductions-drug-resistant-focal-epilepsy</loc><lastmod>2026-05-13T22:00:00Z</lastmod><news:news><news:publication_date>2026-05-13T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Neurostimulation Shows Sustained Seizure Reductions in Drug-Resistant Focal Epilepsy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/navigating-switching-therapy-strategies-in-myasthenia-gravis-audio</loc><lastmod>2026-05-13T20:05:00Z</lastmod><news:news><news:publication_date>2026-05-13T20:05:00Z</news:publication_date>
        <news:title><![CDATA[Navigating Switching Therapy Strategies in Myasthenia Gravis-Audio]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/navigating-switching-therapy-strategies-in-myasthenia-gravis-video</loc><lastmod>2026-05-13T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-13T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Navigating Switching Therapy Strategies in Myasthenia Gravis Video]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>